Stem Cells: US Controversy and UK Commitment
Executive Summary
The debate over stem cells has produced a complex web of rules and regulations on both sides of the Atlantic. In the UK, the UK Stem Cell Foundation was established with the goal of attracting investors willing to support clinical research using stem cells, and to help translate basic research findings into clinically and commercially viable products. In the US, private firms have stepped into the gap created by a lack of federal research funding.
You may also be interested in...
Clinical Update (03/2007)
Recent clinical developments in the medical device industry, including developments in Artificial Limbs, Tissue-Engineered Therapy for ACL Tears, using Genes to Identify Early Atherosclerosis, and Stem Cell News.
Cardio3: Moving from Science Project to Business Model in Stem Cells
Cardiac stem cell therapy for regenerating diseased heart tissue has been long on promise but short on delivery. A Belgian incubator and start-up hope to finally bring this treatment to market.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.